NO983920L - Isoksaszolderivater - Google Patents
IsoksaszolderivaterInfo
- Publication number
- NO983920L NO983920L NO983920A NO983920A NO983920L NO 983920 L NO983920 L NO 983920L NO 983920 A NO983920 A NO 983920A NO 983920 A NO983920 A NO 983920A NO 983920 L NO983920 L NO 983920L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- alkanoyl
- cycloalkenyl
- alkoxycarbonyl
- alkynyl
- Prior art date
Links
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- -1 cyano, carboxy Chemical group 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002545 isoxazoles Chemical class 0.000 abstract 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3981996 | 1996-02-27 | ||
| PCT/JP1997/000583 WO1997031906A1 (fr) | 1996-02-27 | 1997-02-27 | Derives d'isoxazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983920D0 NO983920D0 (no) | 1998-08-26 |
| NO983920L true NO983920L (no) | 1998-10-27 |
Family
ID=12563591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983920A NO983920L (no) | 1996-02-27 | 1998-08-26 | Isoksaszolderivater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6005116A (cs) |
| EP (1) | EP0885891A4 (cs) |
| KR (1) | KR19990087339A (cs) |
| CN (1) | CN1216986A (cs) |
| AU (1) | AU711927B2 (cs) |
| CA (1) | CA2247439A1 (cs) |
| CZ (1) | CZ272598A3 (cs) |
| HU (1) | HUP9900400A3 (cs) |
| NO (1) | NO983920L (cs) |
| RU (1) | RU2165415C2 (cs) |
| WO (1) | WO1997031906A1 (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221854B1 (en) * | 1996-03-05 | 2001-04-24 | Orquest, Inc. | Method of promoting bone growth with hyaluronic acid and growth factors |
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| CN101284773A (zh) * | 2001-08-09 | 2008-10-15 | 小野药品工业株式会社 | 羧酸衍生物及以它为活性成分的药剂 |
| EP2289498A1 (en) * | 2003-10-15 | 2011-03-02 | Probiodrug AG | Use of inhibitors of glutaminyl clyclase |
| WO2005113519A1 (en) * | 2004-05-14 | 2005-12-01 | Irm Llc | Compounds and compositions as ppar modulators |
| KR20080047959A (ko) * | 2006-11-27 | 2008-05-30 | 주식회사 엠디바이오알파 | 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물 |
| AU2007326395B2 (en) * | 2006-12-01 | 2012-10-11 | Msd K.K. | Novel phenyl-isoxazol-3-ol derivative |
| KR101405823B1 (ko) * | 2007-12-24 | 2014-06-12 | 주식회사 케이티앤지생명과학 | 녹내장의 치료 및 예방을 위한 약제 조성물 |
| KR20090071829A (ko) * | 2007-12-28 | 2009-07-02 | 주식회사 머젠스 | 신장질환의 치료 및 예방을 위한 약제 조성물 |
| WO2010033977A2 (en) | 2008-09-22 | 2010-03-25 | Cayman Chemical Company | Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| WO2011052756A1 (ja) | 2009-10-30 | 2011-05-05 | 持田製薬株式会社 | 新規３－ヒドロキシ－５－アリールイソキサゾール誘導体 |
| KR20130004262A (ko) | 2009-12-25 | 2013-01-09 | 모찌다 세이야쿠 가부시끼가이샤 | 신규 3-히드록시-5-아릴이소티아졸 유도체 |
| AU2012248629A1 (en) | 2011-04-27 | 2013-11-28 | Mochida Pharmaceutical Co., Ltd. | Novel 3-hydroxyisothiazole 1-oxide derivative |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2585374B2 (ja) * | 1988-05-31 | 1997-02-26 | 三共株式会社 | イソオキサゾリン−３−オン関連化合物およびその用途 |
| JPS59216881A (ja) * | 1983-05-23 | 1984-12-06 | Sankyo Co Ltd | ３−ヒドロキシイソオキサゾ−ル誘導体の製造法 |
| JPS63152367A (ja) * | 1986-08-25 | 1988-06-24 | Shionogi & Co Ltd | ３―パーフルオロアルキル―５―置換オキシイソオキサゾール誘導体およびそれを有効成分として含有する除草剤 |
| US5321037A (en) * | 1986-12-26 | 1994-06-14 | Sankyo Company, Limited | Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants |
| IE62276B1 (en) * | 1988-03-30 | 1995-01-25 | Sankyo Co | "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants" |
| JP2786684B2 (ja) * | 1989-08-22 | 1998-08-13 | 三共株式会社 | イソオキサゾール化合物を有効成分とする抗うつ剤 |
| US5116839A (en) * | 1989-06-26 | 1992-05-26 | Sankyo Company, Limited | Use of isoxazolin-3-one derivatives as antidepressants |
| JP2786683B2 (ja) * | 1989-08-15 | 1998-08-13 | 三共株式会社 | グリコール誘導体およびその用途 |
| ATE108448T1 (de) * | 1990-05-11 | 1994-07-15 | Sankyo Co | Piperdinyloxy- und chinindidinyloxy- isoxazol- derivate, ihre herstellung und ihre therapeutische verwendung. |
| US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| US5547967A (en) * | 1993-12-08 | 1996-08-20 | Kali-Chemie Pharma Gmbh | (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them |
| PT779281E (pt) * | 1994-08-30 | 2004-02-27 | Sankyo Co | Isoxazoles |
-
1997
- 1997-02-27 CZ CZ982725A patent/CZ272598A3/cs unknown
- 1997-02-27 EP EP97903623A patent/EP0885891A4/en not_active Withdrawn
- 1997-02-27 CN CN97194145A patent/CN1216986A/zh active Pending
- 1997-02-27 KR KR1019980706748A patent/KR19990087339A/ko not_active Withdrawn
- 1997-02-27 AU AU18122/97A patent/AU711927B2/en not_active Ceased
- 1997-02-27 CA CA002247439A patent/CA2247439A1/en not_active Abandoned
- 1997-02-27 WO PCT/JP1997/000583 patent/WO1997031906A1/ja not_active Application Discontinuation
- 1997-02-27 RU RU98117708/04A patent/RU2165415C2/ru active
- 1997-02-27 HU HU9900400A patent/HUP9900400A3/hu unknown
-
1998
- 1998-08-26 NO NO983920A patent/NO983920L/no unknown
- 1998-08-26 US US09/148,905 patent/US6005116A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9900400A3 (en) | 2001-06-28 |
| CA2247439A1 (en) | 1997-09-04 |
| NO983920D0 (no) | 1998-08-26 |
| AU1812297A (en) | 1997-09-16 |
| CN1216986A (zh) | 1999-05-19 |
| EP0885891A4 (en) | 2001-02-21 |
| US6005116A (en) | 1999-12-21 |
| CZ272598A3 (cs) | 1999-01-13 |
| WO1997031906A1 (fr) | 1997-09-04 |
| HUP9900400A2 (hu) | 1999-05-28 |
| KR19990087339A (ko) | 1999-12-27 |
| AU711927B2 (en) | 1999-10-21 |
| RU2165415C2 (ru) | 2001-04-20 |
| EP0885891A1 (en) | 1998-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983920L (no) | Isoksaszolderivater | |
| YU57603A (sh) | Inhibitori fosfodiesteraze 4 | |
| NO20062099L (no) | Synergistiske fungicide aktive substanskombinasjoner | |
| NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
| DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
| DE60233884D1 (de) | 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen | |
| SG169900A1 (en) | 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors | |
| YU41801A (sh) | Derivati fenilglicina | |
| TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| DK1501507T3 (da) | Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet | |
| NO20062337L (no) | Synergistiske fungicidiale aktive forbindelser | |
| NO20062633L (no) | Pyrazolderivater som proteinkinasemodulatorer | |
| DE69821985D1 (de) | Ortho-anthranilamide derivate als antikoagulantien | |
| ES2196396T3 (es) | Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa. | |
| EA200100588A1 (ru) | Пиперидины как модуляторы ccr5 | |
| ATE290382T1 (de) | Heterozyklische kalium-kanal inhibitoren | |
| ATE427300T1 (de) | Heterocyclisch substituierte amide als calpainhemmer | |
| EA200401204A1 (ru) | Сульфонилпроизводные в качестве новых ингибиторов гистон-деацетилазы | |
| MXPA03011722A (es) | Derivados de piperidina utiles como moduladores de actividad de quimiocina. | |
| NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
| NO963706L (no) | Benzenkondenserte heterosykliske derivater og deres anvendelse | |
| EA200000320A1 (ru) | Изохинолины в качестве ингибиторов урокиназы | |
| CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
| DE60209806D1 (de) | 2-amino-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase | |
| ZA200500436B (en) | 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |